Top

Indian Journal of Hematology and Blood Transfusion

25-03-2024 | CORRESPONDENCE

Molecular Screening of VEL01N.01 and AUG02 Alleles in Indian Population: Towards Identifying Rare Blood Donors

Authors: Harita Maru, Roshan Shaikh, Juili Narkar, Ajit Gorakshakar

Published in: Indian Journal of Hematology and Blood Transfusion

Excerpt

Dear Editor, …

Daniels G (2002) Human blood groups. Blackwell Science Ltd, OxfordCrossRef

Cash KL, Brown T, Sausais L, Uehlinger J, Reed LJ (1999) Severe delayed hemolytic transfusion reaction secondary to anti-Ata. Transfusion 39:834–837CrossRefPubMed

Wieckhusen C, Rink G, Scharberg EA, Rothenberger S, Kömürcü N, Bugert P (2015) Molecular screening for Vel-blood donors in southwestern Germany. Transfus Med Hemother 42(6):356–360CrossRefPubMedPubMedCentral

Applewhaite F, Ginsberg V, Gerena J, Cunningham CA, Gavin J (1967) A very frequent red cell antigen Ata. Vox Sang 13:444–445PubMed

Title: Molecular Screening of VEL*01N.01 and AUG*02 Alleles in Indian Population: Towards Identifying Rare Blood Donors
Authors: Harita Maru
Roshan Shaikh
Juili Narkar
Ajit Gorakshakar
Publication date: 25-03-2024
Publisher: Springer India
Published in: Indian Journal of Hematology and Blood Transfusion
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-024-01744-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Keynote webinar | Spotlight on antibody–drug conjugates in cancer